// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Cough monitoring during the covid-19 pandemic

Jaclyn Smith - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective

Dominic Sykes - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Does impact of COVID-19 pandemic reduce A&E attendances, hospital inpatient stays and re-admissions with acute exacerbation of COPD?

Kamal Ibrahim - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Efficacy of azithromycin in a real world severe asthma cohort

Ayesha Kumar - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Azithromycin

Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design

Steven Smith - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Benralizumab

Detection of laryngeal dysfunction in the systematic assessment of severe asthma

Julia Selby - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study

Andrew Menzies-Gow - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Benralizumab

Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

Nasloon Ali - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A questionnaire to measure the extra-pulmonary symptoms of asthma

Giulio De Felice - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Healthcare seeking behaviour in a defined COPD patient population during COVID- 19 pandemic. A mixed method study

suraj rajput - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Asthma hospitalisation and mortality during the first wave of COVID-19

Steven Smith - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A data management and analysis platform for RASP-UK multiomics clinical datasets

nazanin Zounemat Kermani - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Cough Severity Diary in a pooled analysis of two, phase 3 trials of gefapixant in chronic cough

Surinder S. Birring - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Gefapixant

How do cough patterns correlate with novel capsaicin cough challenge parameters?

Kimberley Holt - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Capsaicin

The carnitine pathway is dysregulated in asthma in an oral corticosteroid-independent mechanism

Stacey Reinke - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Carnitine

A Parent Reported Quality of Life Measure for Young Children with Primary Ciliary Dyskinesia: QOL-PCDPR

Laura Behan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Primary ciliary dyskinesia

N/A

Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort

Sarah Rønnow - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Treatable traits in the NOVELTY study: assessing complexity by network analysis

Rosa Faner - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Neutrophilic inflammation in sputum does not define a clinical distinct asthma phenotype in ATLANTIS

Pauline Kuks - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Elastic principal graphs for clinical trajectory analysis in COPD: a COPDGene study

Alexander Bell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Copyright © 2026. QuantiNova All rights reserved